U.S. Luxury Stock News

Taking the occasional loss comes part and parcel with investing on the stock market. Unfortunately, shareholders of...

Wondering if Zevra Therapeutics at around $8 a share is a hidden bargain or just another biotech rollercoaster? You are not alone. Let us break down what the current price might really be telling us. The stock is roughly flat over the last year, down 1.8%, but that sits on top of a wild 84.7% gain over three years and a 55.5% drop over five years. This pattern hints at shifting market confidence rather than a simple growth story. Recent attention has centered on Zevra's progress with its...

Ciena (CIEN) just wrapped up FY 2025 with fourth quarter revenue of about $1.4 billion and basic EPS of $0.14, alongside trailing twelve month revenue of roughly $4.8 billion and EPS of $0.87. The company has seen revenue move from $1.1 billion and EPS of $0.26 in Q4 2024 to the latest $1.4 billion and $0.14. On a trailing basis, revenue has stepped up from about $4.0 billion and EPS of $0.58 to $4.8 billion and $0.87, setting the stage for investors to weigh modest net margins against the...

Forward Industries (FWDI) has just posted a tough FY 2025 finish, with fourth quarter revenue of about $7.9 million and basic EPS of roughly -$6.88, underscoring how challenged profitability remains. The company has seen quarterly revenue move from around $4.7 million in Q4 2024 to $7.9 million in Q4 2025, while basic EPS shifted from about -$0.65 to -$6.88 over the same stretch, highlighting how the top line has not yet translated into healthier margins. See our full analysis for Forward...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Earlier this month, Middleby agreed to sell a 51% stake in its Residential Kitchen business to investment firm 26North, while Jefferies upgraded its rating on the company and highlighted growth potential in Commercial Foodservice. The combination of this portfolio reshaping and a more optimistic analyst view has refocused attention on Middleby’s higher-margin commercial operations and capital allocation plans. Now we’ll examine how Jefferies’ more optimistic outlook on Middleby’s Commercial...

The main point of investing for the long term is to make money. But more than that, you probably want to see it rise...

There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on the bright side, if...

You may think that with a price-to-sales (or "P/S") ratio of 0.4x AstroNova, Inc. ( NASDAQ:ALOT ) is a stock worth...

Cerence Inc. ( NASDAQ:CRNC ) shareholders should be happy to see the share price up 26% in the last month. But will...

Ideally, your overall portfolio should beat the market average. But the main game is to find enough winners to more...

Low-cost index funds make it easy to achieve average market returns. But across the board there are plenty of stocks...

Vinci Compass Investments Ltd.'s ( NASDAQ:VINP ) price-to-earnings (or "P/E") ratio of 25.5x might make it look like a...

When you buy a stock there is always a possibility that it could drop 100%. But on a lighter note, a good company can...

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...

While Odyssey Marine Exploration, Inc. ( NASDAQ:OMEX ) shareholders have enjoyed a good week with stock up 13%, they...

If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...

Shareholders of Vail Resorts, Inc. ( NYSE:MTN ) will be pleased this week, given that the stock price is up 12% to...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") above 20x, you may...

Rent the Runway (RENT) just posted a sharp swing into profitability for Q3 2026, with revenue of about $87.6 million and net income of roughly $76.5 million translating to EPS of around $13.69, while its trailing twelve month figures show revenue of about $314.5 million and net income of roughly $10.6 million, or EPS of about $2.45. Over recent quarters the company has seen revenue move from about $75.9 million in Q3 2025 to $87.6 million in Q3 2026, alongside a turn from a net loss of...

Recent performance and setup Integra LifeSciences Holdings (IART) has quietly climbed about 11% over the past month, even as its one year return remains down more than 40%. This creates an interesting reset for patient investors. See our latest analysis for Integra LifeSciences Holdings. That 11% 1 month share price return stands in sharp contrast to the roughly 42% year to date share price slide and deeply negative multi year total shareholder returns. This suggests recent gains look more...

Kestra Medical Technologies (KMTS) has posted its Q2 2026 results with revenue of about $22.6 million and a basic EPS loss of $0.64, alongside net income excluding extraordinary items of negative $32.8 million, keeping profitability firmly in the red. The company has seen revenue move from $14.7 million in Q2 2025 to $22.6 million in Q2 2026, while quarterly EPS narrowed from a loss of $1.19 to a loss of $0.64 over the same period. Trailing twelve month net losses remain heavy at roughly...

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...